Metabical Case: Pricing‚ Packaging and Demand Forecasting Case Brief Demand Forecasting Packaging and Count Decision Pricing Strategy Introduction of new weight loss drugMetabical What is the expected demand? What are the factors deciding packaging count decisions? How many tablets in a packet of drug? What should be the pricing strategy? ROI Demand Forecastin g Case Brief Packaging and Count Decision Pricing Strategy ROI Demand Forecast: Option One Population Actively Overweight trying
Premium Supply and demand Pricing Household income in the United States
Metabical: Positioning and Communications Strategy for a new Weight-Loss Drug Q & A 1. Who is involved in the decision making process? What is the decision making process for Metabical? Since Metabical is a prescription drug for weight loss which can only be bought via a prescription‚ the overweight patients are not the only decision makers involved. The health care providers are also decision makers in this process for they are the ones who prescribe the drug. The consumer decision
Premium Marketing Obesity Medicine
Metabical: Positioning and Communications Strategy for a New Weight-Loss Drug Case Study Case Article:Click Here Questions for Analysis 1. Metabical is faced with the task of positioning their product in the marketplace. Using the information from the case and your assigned readings‚ who are the key target segments for Metabical and what points of difference should be directed to each segment? Key Segments for Metabical are 1. End consumer(the patient) - Over weight adults
Premium Health care Medicine Marketing
HBS Case: Metabical: Positioning and Communications Strategy for a New Weight Loss Drug 1. What is the decision-making process for Metabical? Who is involved? Metabical needs to decide whom to sell and what means to use in order to reach this group successfully. This decision has to be taken by Printup and her marketing team. The target market should be identified; first of all‚ the segmentation of the market needs to be done in order to analyze which segment of the market would be more attracted
Premium Obesity Weight loss Medicine
Questions for the Harvard case “Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug” For March 20‚ write responses to the following questions for the Metabical case. 1) How is Metabical different from the existing weight-loss options? How is it better or worse than the other options? Metabical is the first prescription drug approved specifically for overweight individuals (BMI between 25 and 30)‚ those individuals who have weight-loss goals of approximately
Premium Obesity Weight loss Nutrition
Hello Metabical Positioning And Communications Strategy For a New Weight Loss Drug Harvard Business Essays and Term Papers Search Results for ’metabical positioning and communications strategy for a new weight loss drug harvard business ’ Displaying 1 - 30 of 1‚500 * Metabical: Positioning And Communications Strategy For a New Weight-Loss Drug Metabical: Positioning and Communications Strategy for a new Weight-Loss Drug Q & A 1. Who is involved in the decision making process? What
Premium Marketing Weight loss
* Weight-loss drugs Market before Metabical * Prevailing Safety Concerns; limiting options for patients * No prescription-drug option for the overweight segment (BMI 25-30) * Many OTC drugs available for patients with BMI 30+ including FDA-approved ‘Alli’ but various negative side effects reported‚ e.g.‚ 30 liver damage cases in Alli & Xenical during ‘99-‘08 * Other solutions categorized as herbal or dietary supplements were not regulated by the FDA i.e.‚ safety not warranted
Premium Obesity Medicine Weight loss
1. What makes Metabical different from the other weight-loss products on the market? Medibical is the first FDA-approved prescription drug for the overweight segment (BMI 25-30). It is a low-dose formula that reduces stress on heart and liver functions. Metabical also contains a controlled-release feature that requires only one pill be taken per day which leads to better patient compliance. Participants experience dramatic weight loss with an average 26 pounds for BMI 28-30 and 15 pounds for BMI
Premium Obesity Nutrition Dieting
INDIVIDUAL CASE STUDY METABICAL: _POSITIONING & COMMUNICATIONS STRATEGY_ _FOR A NEW WEIGHT-LOSS DRUG_ Q1: WHAT IS THE DECISION-MAKING PROCESS FOR METABICAL? WHO IS INVOLVED IN THE PROCESS? Consumer research over the years has shown that shoppers often follow a relatively common shopping behavior for product purchase. In theory‚ a shopper is said to go through the following five stages as a process. In reality‚ sometimes the steps may be switched around or even left out‚ as not all consumers
Premium Obesity Medicine Weight loss
1. What is the decision-making process for Metabical? Who is involved in the process? Market research: investigating into the overall adult overweight situation in U.S. fand overweight population and consumers’ perception of the currently existed weight-loss drugs. Analyzing differential advantages: CSP should recognize the Metabical’s competitive factors first. Metabical is the first prescription drug approved by FDA and has less negative side effect and can magically loss weight. Recognizing
Premium Obesity Weight loss Health